Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies

Long non coding RNAs (lncRNAs) are non-protein or low-protein coding transcripts that contain more than 200 nucleotides. They representing a large share of the cell's transcriptional output, demonstrate functional attributes viz. tissue-specific expression, determination of cell fate, controlle...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nirjhar Bhattacharyya, Vedansh Pandey, Malini Bhattacharyya, Abhijit Dey
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/91ce3bb776904e07a012256c863dd970
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:91ce3bb776904e07a012256c863dd970
record_format dspace
spelling oai:doaj.org-article:91ce3bb776904e07a012256c863dd9702021-11-20T04:57:40ZRegulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies1818-087610.1016/j.ajps.2021.02.006https://doaj.org/article/91ce3bb776904e07a012256c863dd9702021-09-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1818087621000313https://doaj.org/toc/1818-0876Long non coding RNAs (lncRNAs) are non-protein or low-protein coding transcripts that contain more than 200 nucleotides. They representing a large share of the cell's transcriptional output, demonstrate functional attributes viz. tissue-specific expression, determination of cell fate, controlled expression, RNA processing and editing, dosage compensation, genomic imprinting, conserved evolutionary traits etc. These long non coding variants are well associated with pathogenicity of various diseases including the neurological disorders like Alzheimer's disease, schizophrenia, Huntington's disease, Parkinson's disease etc. Neurological disorders are widespread and there knowing the underlying mechanisms become crucial. The lncRNAs take part in the pathogenesis by a plethora of mechanisms like decoy, scaffold, mi-RNA sequestrator, histone modifiers and in transcriptional interference. Detailed knowledge of the role of lncRNAs can help to use them further as novel biomarkers for therapeutic aspects. Here, in this review we discuss regulation and functional roles of lncRNAs in eight neurological diseases and psychiatric disorders, and the mechanisms by which they act. With these, we try to establish their roles as potential markers and viable diagnostic tools in these disorders.Nirjhar BhattacharyyaVedansh PandeyMalini BhattacharyyaAbhijit DeyElsevierarticleNon coding rnasAlzheimer's diseaseHuntington's diseaseParkinson's diseaseSchizophreniaRegulatoryTherapeutics. PharmacologyRM1-950ENAsian Journal of Pharmaceutical Sciences, Vol 16, Iss 5, Pp 533-550 (2021)
institution DOAJ
collection DOAJ
language EN
topic Non coding rnas
Alzheimer's disease
Huntington's disease
Parkinson's disease
Schizophrenia
Regulatory
Therapeutics. Pharmacology
RM1-950
spellingShingle Non coding rnas
Alzheimer's disease
Huntington's disease
Parkinson's disease
Schizophrenia
Regulatory
Therapeutics. Pharmacology
RM1-950
Nirjhar Bhattacharyya
Vedansh Pandey
Malini Bhattacharyya
Abhijit Dey
Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies
description Long non coding RNAs (lncRNAs) are non-protein or low-protein coding transcripts that contain more than 200 nucleotides. They representing a large share of the cell's transcriptional output, demonstrate functional attributes viz. tissue-specific expression, determination of cell fate, controlled expression, RNA processing and editing, dosage compensation, genomic imprinting, conserved evolutionary traits etc. These long non coding variants are well associated with pathogenicity of various diseases including the neurological disorders like Alzheimer's disease, schizophrenia, Huntington's disease, Parkinson's disease etc. Neurological disorders are widespread and there knowing the underlying mechanisms become crucial. The lncRNAs take part in the pathogenesis by a plethora of mechanisms like decoy, scaffold, mi-RNA sequestrator, histone modifiers and in transcriptional interference. Detailed knowledge of the role of lncRNAs can help to use them further as novel biomarkers for therapeutic aspects. Here, in this review we discuss regulation and functional roles of lncRNAs in eight neurological diseases and psychiatric disorders, and the mechanisms by which they act. With these, we try to establish their roles as potential markers and viable diagnostic tools in these disorders.
format article
author Nirjhar Bhattacharyya
Vedansh Pandey
Malini Bhattacharyya
Abhijit Dey
author_facet Nirjhar Bhattacharyya
Vedansh Pandey
Malini Bhattacharyya
Abhijit Dey
author_sort Nirjhar Bhattacharyya
title Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies
title_short Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies
title_full Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies
title_fullStr Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies
title_full_unstemmed Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies
title_sort regulatory role of long non coding rnas (lncrnas) in neurological disorders: from novel biomarkers to promising therapeutic strategies
publisher Elsevier
publishDate 2021
url https://doaj.org/article/91ce3bb776904e07a012256c863dd970
work_keys_str_mv AT nirjharbhattacharyya regulatoryroleoflongnoncodingrnaslncrnasinneurologicaldisordersfromnovelbiomarkerstopromisingtherapeuticstrategies
AT vedanshpandey regulatoryroleoflongnoncodingrnaslncrnasinneurologicaldisordersfromnovelbiomarkerstopromisingtherapeuticstrategies
AT malinibhattacharyya regulatoryroleoflongnoncodingrnaslncrnasinneurologicaldisordersfromnovelbiomarkerstopromisingtherapeuticstrategies
AT abhijitdey regulatoryroleoflongnoncodingrnaslncrnasinneurologicaldisordersfromnovelbiomarkerstopromisingtherapeuticstrategies
_version_ 1718419728298409984